|
|
|
|
|
Authors’ reply |
2563 |
# |
|
|
|
|
|
Authorship Considerations What Qualifies? |
2559 |
# |
|
|
|
|
|
Autoantibody profiles and clinical association in Thai patients with autoimmune retinopathy |
2564 |
# |
|
|
|
|
|
Autoantibody-dependent amplification of inflammation in SLE |
2563 |
# |
|
|
|
|
|
Autoimmune and rheumatic manifestations and antinuclear antibody study in HIV-infected Thai patients. |
2545 |
# |
|
|
|
|
|
Autoimmune hemolytic anemia and venous thromboembolism: A systematic review and meta-analysis. |
2558 |
# |
|
|
|
|
|
Autoimmune Pancreatitis and IgG4-related Cholangitis: A Single-center Experience |
2563 |
# |
|
|
|
|
|
Autoimmunity and HIV/simian immunodeficiency virus infection: A two edged sword |
2550 |
# |
|
|
|
|
|
Autologous fat transplantation in patients with breast cancer: "silencing" or "fueling" cancer recurrence? |
2554 |
# |
|
|
|
|
|
Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica |
2562 |
# |
|
|
|
|
|
Autologous serum skin test in chronic idiopathic urticaria: prevalence, correlation and clinical implications. |
2549 |
# |
|
|
|
|
|
Automated segmentation of lung, liver, and liver tumors from Tc-99m MAA SPECT/CT images for Y-90 radioembolization using convolutional neural networks |
2564 |
# |
|
|
|
|
|
Autophagic degradation of aquaporin-2 is an early event in hypokalemia-induced nephrogenic diabetes insipidus |
2558 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |
|
|
|
|
|
Autosomal dominant diabetes associated with a novel ZYG11A mutation resulting in cell cycle arrest in beta-cells |
2564 |
# |